
A new clinical trial will investigate whether people who are highly allergic or have what’s known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines. “The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech… read on > read on >